No Detail Found!

Ameliorating effect of a Beta-blocker, Propranolol on Carbamazepine-induced Hepatotoxicity in Rabbits.

Author(s)
Hina Abrar Department of Pharmacology, Baqai Medical University, Super Highway, Gadap Road, P.O Box-2407, Karachi, Pakistan: Dow College of Pharmacy, Dow University of Health Sciences, Ojha Campus, Gulzar e Hijri, Scheme-33, Suparco Road, Karachi, Pakistan
S N H Naqvi Department of Pharmacology, Baqai Medical University, Super Highway, Gadap Road, P.O Box-2407, Karachi, Pakistan
Muhammad Rashid Ahmed Department of Anatomy, Baqai Medical University, Super Highway, Gadap Road, P.O Box-2407, Karachi, Pakistan
Asma Basharat Ali Department of Anatomy, Baqai Medical University, Super Highway, Gadap Road, P.O Box-2407, Karachi, Pakistan
Hina Yasin Department of Pharmacology, Baqai Medical University, Super Highway, Gadap Road, P.O Box-2407, Karachi, Pakistan: Dow College of Pharmacy, Dow University of Health Sciences, Ojha Campus, Gulzar e Hijri, Scheme-33, Suparco Road, Karachi, Pakistan
Abstract
Propranolol is non cardioselective beta blocker used to treat various cardiac and non-cardiac diseases including arrhythmia, hypertension, portal hypertension and oesophageal varices. The study was undertaken in rabbits to investigate the effect of propranolol to reduce hepatoxicity of carbamazepine (CBZ). Animals were divided into three groups; control, CBZ administered group (200 mg/Kg for 10 days) and CBZ plus propranolol (30 mg/Kg for 10 days) treated group. Liver function test and histological evaluation by H and E staining and scanning electron microscopy (SEM) was carried at the end of dosing by using standard procedures. Serum level of ALT, ALP, ?GT and bilirubin was significantly (p<0.05) increased in CBZ treated group as compared to control, whereas the hepatic parameters were significantly reduced in CBZ plus propranolol group. The histopathological examination reveals various features of hepatic architecture damage in CBZ treated group but the hepatic damage induced by CBZ was successfully ameliorated by propranolol. To conclude propranolol is effective in reducing the hepatoxic effects of CBZ probably by affecting hepatic blood flow.
Publication Details
Page(s) 341-346
Published Journal: Pakistan Journal of Zoology, Volume: 51, Issue: 1, Year: 2019

Request the full text from PASTIC

References
Adali , M.,İnal-Erden,Akalin , A.,Efe , B.N., 1999.Effects of propylthiouracil, propranolol, and vitamin E on lipid peroxidation and antioxidant status in hyperthyroid patients,Clin. Biochem 9120 00024 -7
Ahmed , S.N.,Siddiqi , Z.A., 2005.Antiepileptic drugs and liver disease,Seizure 12 156 -164
Bosch , J.,Masti , R.,Kravetz , D.,Bruix , J.,Gaya , J.,Rigau , J.,Rodes , J., 1984.Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis,Hepatology 4 1200 -1205
Cengiz , M.,Ali , J.H.,Kutlu , M,,Vejselova , D.,Ayhanci , A., 2017.Potential recruiting and hepatoprotective effects of ellagic acid in D-galactosamine-induced liver damage in rats,Pakistan J. Zool. 49 1251 -1259
Chalasani , N.,Bjornsson , E., 2010.Risk factors for idiosyncratic drug-induced liver injury,Gastroenterology 04 2246 -2259
Chalasani , N.,Bonkovsky , H.L.,Fontana , R.,Lee , W.,Stolz , A.,Talwalkar , J.,Reddy , K.R.,Watkins , P.B.,Navarro , V.,Barnhart , H.,Gu , J.,Serrano , J., 2015.Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study,Gastroenterology 03 1340 -1352
Chalasani , N.,Fontana , R.J.,Bonkovsky , H.L.,Watkins , P.B.,Davern , T.,Serrano , J.,Yang , H.,Rochon , J., 2008.Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States, 09 1924 -1934
Chen , M.,Suzuki , A.,Borlak , J.,Andrade , R.J.,Lucena , M.I., 2015.Drug-induced liver injury: Interactions between drug properties and host factors,J. Hepatol. 04 503 -514
Echlin , P., 2011.Handbook of sample preparation for scanning electron microscopy and X-ray microanalysis, -
Eghbal , M.A.,Taziki , S.,Sattari , M.R., 2013.Protective role of melatonin and taurine against carbamazepine-induced toxicity in freshly isolated rat hepatocytes,Int. J. Morphol. 1 1081 -1089
Elliott , E.C.,Regan , S.L.,Maggs , J.L.,Bowkett , E.R.,Parry , L.J.,Williams , D.P.,Park , B.K.,Stachulski , A.V., 2012.Haloarene derivatives of carbamazepine with reduced bioactivation liabilities: 2-monohalo and 2,8-dihalo derivatives,J. med. Chem 55 9773 -9784
George , M.,Joseph , L., 2016.A review article on assessing the effect of antiepileptics and statins on liver enzymes in epileptic patients,Pharma Innov. J. 5 11 -14
Higuchi , S.,Yano , A.,Takai , S.,Tsuneyama , K.,Fukami , T.,Nakajima , M.,Yokoi , T., 2012.Metabolic activation and inflammation reactions involved in carbamazepine-induced liver injury,Toxicol. Sci. 130 4 -16
Huang , Y.T., Cheng, Y.R.,Lin , H.C.,Hou , M.C.,Lee , S.D.,Hong, 1998.Hemodynamic effects of eight-day octreotide and propranolol administration in portal hypertensive rats,Digest. Dis. Sci. 43 358 -364
Kim , C.H.,Younossi , Z.M., 2008.Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome,Cleveland Clin. J. Med 75 721 -728
Lee , J.Y.,Huo , T.I.,Huang , H.C.,Lee , F.Y.,Lin , H.C.,Chuang , C.L.,Chang , C.C.,Wang , S.S.,Lee , S.D., 2011.Propranolol modulates the collateral vascular responsiveness to vasopressin via a Gα- mediated pathway in portal hypertensive rats,Clin. Sci. 121 545 -554
Maheswari , E.,Saraswathy , G.R.,T., 2014.Hepatoprotective and antioxidant activity of N-acetyl cysteine in carbamazepine-administered rats,Indian J. Pharmacol. 46 129321 -7613
Maheswari , E.,Saraswathy , G.R.,Raja , G.,Santhranii , T., 2015a.Effectiveness of alpha lipoic acid as hepatoprotective and antioxidant,Int. J. Pharmaceut. Chem. biol. Sci. 5 242 -248
Maheswari , E.,Saraswathy , G.,Santhranii , T., 2015b.Influence of vitamin E on hepatotoxicity and oxidative stress,Int. J. Res. Pharm. Biosci. 2 30 -38
Mak , I.T.,Weglicki, 2004.Potent antioxidant properties of 4-hydroxyl-propranolol,J. Pharmacol. exp. Therap. 308 85 -90
Mesdjian , E.,Zamora , A.J.,Montet , A.M.,Bonneton , J.,Guitaoui , M.,Genton , P.,Montet , J. C., 1996.Ursodeoxycholate improves hepatobiliary dysfunction induced by valproate-carbamazepine treatment in the rat,Life Sci 59 00422 -5
Ohnishi , K.,Nakayama , T.,Saito , M.,Hatano , H.,Tsukamoto , T.,Terabayashi , H.,Sugita , S.,Wada , K.,Nomura , F.,Koen , H.,Okuda , K., 1985.Effects of propranolol on portal hemodynamics in patients with chronic liver disease,Am. J. Gastroenterol. 80 132 -135
Pandit , A.,Sachdeva , T.,Bafna , P., 2012.Druginduced hepatotoxicity: A review,J. appl. Pharmaceut. Sci. 2 233 -243
Parasuraman , S.,Raveendran , R.,Kesavan , R., 2010.Blood sample collection in small laboratory animals,J. Pharmacol. Pharmacother. 1 72350 -500X
Pérez-Paramo , M.,Munoz , J.,Albillos , A.,Freile , I.,Portero , F.,Santos , M.,Ortiz-Berrocal , J., 2000.Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites,Hepatology 31 43 -48
Piao , M.,Liu , Y.,Yu , T.,Lu , Y., 2016.Zinc supplementation ameliorates ER stress and autophagy in liver in a rat model of type 2 diabetes mellitus,Biomed. Res. 27 970 -938
Pizcueta , M.P.,de Lacy , A.M.,Kravetz , D.,Bosch , J.,Rodés , J., 1989.Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats,Hepatology 10 953 -957
Prkacin , I.,Separovic , J.,Aralicia , G.,Perovic , D.,Gjurasin , M.,Lovric-Bencic , M.,Stancic-Rokotov , D.,Staresinic , M.,Anic , T.,Mikus , D., 2001.and propranolol, but not ranitidine,J. Physiol. 4257 00044 -4
Santhrani , T.,Maheswari , E.,Saraswathy , G.R., 2013.Carbamazepine provoked hepatotoxicity: Attenuation by vitamin C. Oxidant, 2 37 -43
Santos , N.A.,Medina , W.S.,Martins , N.M.,Rodrigues , M.A.,Curti , C.,Santos , A.C., 2008.Involvement of oxidative stress in the hepatotoxicity induced by aromatic antiepileptic drugs,Toxicol 08 1820 -1824
Sasaki , E.,Iida , A.,Oda , S.,Tsuneyama , K.,Fukami , T.,Nakajima , M.,Yokoi , T., 2015.Pathogenetic analyses of carbamazepine-induced liver injury in F344 rats focused on immune-and inflammationrelated factors,Exp. Toxicol 09 27 -38
Shi , L.,Dang , X.L.,Liu , X.Y.,Wei , H.M.,Yang , M.,Zhang, 2014.Effect of Sophora flavescens on the pharmacokinetics of carbamazepine in rats,Arch. Pharm. Res. 37 1617 -1623
Tarantino , G.,DiMinno,M.N. and Capone,D., 2009.Drug-induced liver injury: Is it somehow foreseeable?,World J. Gastroenterol. 15 2817 -2833
Thapa , B.,Walia , A., 2007.Liver function tests and their interpretation,Indian J. Pediat. 74 663 -671
Tursi , T., 2010.Use of ss-blocker therapy to prevent primary bleeding of esophageal varices,J. Am. Acad. Nurse Pract 00567 7599 -647
Zheng , E.,Navarro , V., 2016.Drug-induced liver injury in the United States: A review of multiingredient supplements,Clin. Liver Dis 7 60 -63
0

Citations

0

Downloads

121

Views